AXL tyrosine kinase inhibitor TP-0903 induces ROS trigger neuroblastoma cell apoptosis via targeting the miR-335-3p/DKK1 expression
Abstract Neuroblastoma (NB) is an aggressive cancer and has poor prognosis in children. TP-0903, a multi-kinase inhibitor, shows inhibitory effects on NB but the mechanistic act is not completely explored. Here, we aimed to explore the anticancer activity of TP-0903 against NB cells and its underlyi...
Saved in:
| Main Authors: | Tsai-Yi Tseng, Shao-Hsuan Kao, Shun-Fa Yang, Yi-Chen Lin, Chu-Liang Lin, Juei-Liang Chen, Chien-Min Chen, Yi-Hsien Hsieh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-08-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-025-02681-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
by: Bhavana Bhatnagar, et al.
Published: (2025-04-01) -
LncRNA-MALAT1-mediated Axl promotes cell invasion and migration in human neuroblastoma
by: Shaojie Bi, et al.
Published: (2017-05-01) -
Targeting DKK3 to remodel tumor immune microenvironment and enhance cancer immunotherapy
by: Kai Shi, et al.
Published: (2025-04-01) -
DNA methylation of DKK‐1 may correlate with pathological bone formation in ankylosing spondylitis
by: Yu‐Cong Zou, et al.
Published: (2023-07-01) -
Pharmacokinetic evaluation and bioavailability of KPT-335 (Verdinexor) in cats
by: Yuxin Yang, et al.
Published: (2025-05-01)